Showing studies matching your search3 results shown
Studies (3 shown)
NCT07416162NOT_YET_RECRUITING
A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy
Sponsor · Novartis PharmaceuticalsCondition · Paroxysmal Nocturnal Hemoglobinuria, C3 GlomerulopathyUpdated Apr 2026
NCT07156149RECRUITING
Fabhalta Capsules Specified Drug-use Survey
Sponsor · Novartis PharmaceuticalsCondition · C3 GlomerulopathyUpdated Apr 2026
NCT06903234ACTIVE_NOT_RECRUITING
Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry
Sponsor · Novartis PharmaceuticalsCondition · Hemoglobinuria, ParoxysmalIntervention · IptacopanUpdated May 2025
Showing top 3 results. See all 3 results on CT.gov →